chitosan lauramide succinamide은 임신 중 안전한가요?
No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
Related ingredients
Frequently asked questions
- chitosan lauramide succinamide은 임신 중 안전한가요?
- No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
- chitosan lauramide succinamide은 모유 수유 중 안전한가요?
- No data located indicating reproductive or lactation-related hazard, no harmonised classification, and no SCCS/CIR contraindication for breastfeeding. Topical cosmetic use of polymeric chitosan derivatives typically shows low systemic absorption; no studies found showing transfer into breast milk for this derivative.
- chitosan lauramide succinamide은 아기 피부에 안전한가요?
- No specific infant-skin safety or absorption studies were located for chitosan lauramide succinamide. Following your scoring rules, because there is measurable (but low) potential for topical absorption for modified chitosan derivatives and infants have higher surface-area-to-weight and immature barrier, exposure (e) is increased by +1 vs adult (from 0 to 1). No infant-specific hazard or mechanism evidence was found to raise h or m.
- VeriMom은 chitosan lauramide succinamide을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 chitosan lauramide succinamide을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 chitosan lauramide succinamide 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.